Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modeling Determinants of Medication Attitudes and Poor Adherence in Early Nonaffective Psychosis: Implications for Intervention
Richard Drake, Merete Nordentoft, Gillian Haddock, et al.
Schizophrenia Bulletin (2015) Vol. 41, Iss. 3, pp. 584-596
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes, Richard Drake, Carol Paton, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 1, pp. 3-78
Open Access | Times Cited: 513
Mobile Phone Ownership and Endorsement of “mHealth” Among People With Psychosis: A Meta-analysis of Cross-sectional Studies
Joseph Firth, Jack Cotter, John Torous, et al.
Schizophrenia Bulletin (2015) Vol. 42, Iss. 2, pp. 448-455
Open Access | Times Cited: 361
Insight in schizophrenia spectrum disorders: relationship with behavior, mood and perceived quality of life, underlying causes and emerging treatments
Paul H. Lysaker, Michelle L. Pattison, Bethany L. Leonhardt, et al.
World Psychiatry (2018) Vol. 17, Iss. 1, pp. 12-23
Open Access | Times Cited: 202
Is It Possible to Predict the Future in First-Episode Psychosis?
Jaana Suvisaari, Outi Mantere, Jaakko Keinänen, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 83
Medication adherence in schizophrenia: The role of insight, therapeutic alliance and perceived trauma associated with psychiatric care
A. Tessier, Laurent Boyer, Mathilde M. Husky, et al.
Psychiatry Research (2017) Vol. 257, pp. 315-321
Closed Access | Times Cited: 61
The association between insight and depressive symptoms in schizophrenia: Undirected and Bayesian network analyses
Mario Amore, Martino Belvederi Murri, Pietro Calcagno, et al.
European Psychiatry (2020) Vol. 63, Iss. 1
Open Access | Times Cited: 33
The effect of mindfulness-based psychoeducation on insight and medication adherence of schizophrenia patients
Nurdan Çetin, Rukuye Aylaz
Archives of Psychiatric Nursing (2018) Vol. 32, Iss. 5, pp. 737-744
Closed Access | Times Cited: 38
Factors Affecting Medication Adherence in Children Receiving Outpatient Pharmacotherapy and Parental Adherence
Masaharu Nagae, Hideyuki Nakane, Sumihisa Honda, et al.
Journal of Child and Adolescent Psychiatric Nursing (2015) Vol. 28, Iss. 2, pp. 109-117
Open Access | Times Cited: 32
Insight and gender in schizophrenia and other psychoses
Jesús Cobo, Lourdes López Nieto, Susana Ochoa, et al.
Psychiatry Research (2016) Vol. 243, pp. 268-277
Closed Access | Times Cited: 29
Schizophrenia and medication adherence: Associated factors
Buse Karabulut, Esra Uslu
Archives of Psychiatric Nursing (2024) Vol. 49, pp. 47-54
Closed Access | Times Cited: 3
Effect of continued cannabis use on medication adherence in the first two years following onset of psychosis
Tabea Schoeler, Natalia Petros, Marta Di Forti, et al.
Psychiatry Research (2017) Vol. 255, pp. 36-41
Open Access | Times Cited: 24
Eficacia, eficiencia y efectividad en el tratamiento multidimensional de la esquizofrenia: proyecto Rethinking
Benedicto Crespo‐Facorro, Miquel Bernardo, Josep María Argimón, et al.
Revista de Psiquiatría y Salud Mental (2016) Vol. 10, Iss. 1, pp. 4-20
Closed Access | Times Cited: 19
Exploring service users’, carers’ and professionals’ perspectives and experiences of current antipsychotic prescribing: A qualitative study
Kamelia Harris, Helen Brooks, Garry Lythgoe, et al.
Chronic Illness (2017) Vol. 13, Iss. 4, pp. 275-287
Closed Access | Times Cited: 19
Characteristics associated with self-reported medication adherence in persons with psychosis referred to psychosocial rehabilitation centers
Hélène Verdoux, Clélia Quilès, Laura Bon, et al.
European Archives of Psychiatry and Clinical Neuroscience (2020) Vol. 271, Iss. 8, pp. 1415-1424
Closed Access | Times Cited: 18
Risk and Prevention of Aggression in Patients With Psychotic Disorders
Margo D. M. Faay, Iris E. Sommer
American Journal of Psychiatry (2021) Vol. 178, Iss. 3, pp. 218-220
Open Access | Times Cited: 16
Medication adherence in first episode psychosis: the role of pre‐onset subthreshold symptoms
Jean-Gabriel Daneault, Anika Maraj, Martín Lepage, et al.
Acta Psychiatrica Scandinavica (2019) Vol. 139, Iss. 4, pp. 336-347
Open Access | Times Cited: 16
Digital Community Inclusion of Individuals With Serious Mental Illness: A National Survey to Map Digital Technology Use and Community Participation Patterns in the Digital Era
Carmit‐Noa Shpigelman, Amir Tal, Yaara Zisman‐Ilani
JMIR Mental Health (2021) Vol. 8, Iss. 9, pp. e28123-e28123
Open Access | Times Cited: 13
Citalopram in first episode schizophrenia: The DECIFER trial
Donald Goff, Oliver Freudenreich, Corrine Cather, et al.
Schizophrenia Research (2019) Vol. 208, pp. 331-337
Open Access | Times Cited: 14
Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial
Brooke C. Schneider, Martin Brüne, Francesca Bohn, et al.
BMC Psychiatry (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 12
Effectiveness, efficiency and efficacy in the multidimensional treatment of schizophrenia: Rethinking project
Benedicto Crespo‐Facorro, Miquel Bernardo, Josep María Argimón, et al.
Revista de Psiquiatría y Salud Mental (English Edition) (2017) Vol. 10, Iss. 1, pp. 4-20
Closed Access | Times Cited: 11
Cognitive insight is correlated with cognitive impairments and contributes to medication adherence in schizophrenia patients
Simon S. Y. Lui, J. Lam, Joanna W.S. Lam, et al.
Asian Journal of Psychiatry (2021) Vol. 60, pp. 102644-102644
Closed Access | Times Cited: 10
Effect of cognitive insight on clinical insight from pre-morbid to early psychosis stages
Lihua Xu, Di Hao, YanYan Wei, et al.
Psychiatry Research (2022) Vol. 313, pp. 114613-114613
Closed Access | Times Cited: 7
Positive and meaningful lives: Systematic review and meta‐analysis of eudaimonic well‐being in first‐episode psychosis
John Gleeson, Dina Eleftheriadis, Olga Santesteban‐Echarri, et al.
Early Intervention in Psychiatry (2020) Vol. 15, Iss. 5, pp. 1072-1091
Closed Access | Times Cited: 9
Dynamics between insight and medication adherence in first-episode psychosis: Study of 3-year trajectories
Julien Elowe, Julie Ramain, Alessandra Solida, et al.
European Psychiatry (2022) Vol. 65, Iss. 1
Open Access | Times Cited: 6
Exploring the relationship of insight with psychopathology and gender in individuals with schizophrenia spectrum disorders with structural equation modelling
Jesús Cobo, Javier Labad, Esther Pousa, et al.
Archives of Women s Mental Health (2020) Vol. 23, Iss. 5, pp. 643-655
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top